Form 8-K - Current report:
SEC Accession No. 0001683168-20-002057
Filing Date
2020-06-25
Accepted
2020-06-25 08:44:47
Documents
25
Period of Report
2020-06-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cns_8k.htm 8-K 19395
2 CNS PHARMACEUTICALS, INC. INVESTOR PRESENTATION - JUNE 2020 cns_ex9901.htm EX-99.1 38854
3 GRAPHIC image_001.jpg GRAPHIC 61503
4 GRAPHIC image_002.jpg GRAPHIC 71541
5 GRAPHIC image_003.jpg GRAPHIC 98061
6 GRAPHIC image_004.jpg GRAPHIC 115920
7 GRAPHIC image_005.jpg GRAPHIC 62543
8 GRAPHIC image_006.jpg GRAPHIC 115606
9 GRAPHIC image_007.jpg GRAPHIC 112869
10 GRAPHIC image_008.jpg GRAPHIC 93276
11 GRAPHIC image_009.jpg GRAPHIC 124209
12 GRAPHIC image_010.jpg GRAPHIC 83855
13 GRAPHIC image_011.jpg GRAPHIC 76348
14 GRAPHIC image_012.jpg GRAPHIC 74332
15 GRAPHIC image_013.jpg GRAPHIC 104359
16 GRAPHIC image_014.jpg GRAPHIC 100021
17 GRAPHIC image_015.jpg GRAPHIC 124821
18 GRAPHIC image_016.jpg GRAPHIC 96095
19 GRAPHIC image_017.jpg GRAPHIC 142105
20 GRAPHIC image_018.jpg GRAPHIC 71437
21 GRAPHIC image_019.jpg GRAPHIC 80038
22 GRAPHIC image_020.jpg GRAPHIC 160700
23 GRAPHIC image_021.jpg GRAPHIC 89397
24 GRAPHIC image_022.jpg GRAPHIC 124972
25 GRAPHIC image_023.jpg GRAPHIC 61442
  Complete submission text file 0001683168-20-002057.txt   3155125
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39126 | Film No.: 20987104
SIC: 2834 Pharmaceutical Preparations